Unique Ingredient Identifier H77VEI93A8 is listed as a ingredient substance
| RN | 2783-94-0 |
| EC | 220-491-7 |
| NCIT | C71636 |
| RXCUI | 1305574 |
| MF | C16H10N2O7S2.2Na |
| INCHI KEY | OIQPTROHQCGFEF-QIKYXUGXSA-L |
| SMILES | [Na+].[Na+].OC1=CC=C2C=C(C=CC2=C1\N=N\C3=CC=C(C=C3)S([O-])(=O)=O)S([O-])(=O)=O |
UNII H77VEI93A8 FD&C YELLOW NO. 6 is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| INHALATION | POWDER | 0.12 MG |
| INHALATION | SOLUTION | NA |
| ORAL | CAPSULE | 0.96 MG |
| ORAL | CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN, PERL | NA |
| ORAL | CAPSULE, COATED PELLETS | 0.002 MG |
| ORAL | CAPSULE, DELAYED ACTION | 0.07 MG |
| ORAL | CAPSULE, DELAYED ACTION, ENTERIC COATED | NA |
| ORAL | CAPSULE, ENTERIC COATED PELLETS | 0.028 MG |
| ORAL | CAPSULE, EXTENDED RELEASE | 0.91 mg |
| ORAL | CAPSULE, HARD GELATIN | 0.001 MG |
| ORAL | CAPSULE, SOFT GELATIN | 0.8 MG |
| ORAL | CAPSULE, SOFT GELATIN LIQUID-FILLED | 0.13 MG |
| ORAL | CAPSULE, SUSTAINED ACTION | 4.59 MG |
| ORAL | CONCENTRATE | 0.03 MG/5ML |
| ORAL | DROPS | NA |
| ORAL | LIQUID | 0.006 MG/5ML |
| ORAL | POWDER | 20 MG/1PKT |
| ORAL | POWDER, FOR ORAL SUSPENSION | 0.65 MG/5ML |
| ORAL | POWDER, FOR RECONSTITUTION | NA |
| ORAL | POWDER, FOR SOLUTION | 4 MG |
| ORAL | POWDER, FOR SUSPENSION | 2 MG/5ML |
| ORAL | SOLUTION | 75.3 MG/15ML |
| ORAL | SOLUTION | 3.54 mg |
| ORAL | SOLUTION | 1.8 mg/15 mL |
| ORAL | SOLUTION, ELIXIR | 4 % |
| ORAL | SUSPENSION | 5 MG/5ML |
| ORAL | SUSPENSION, EXTENDED RELEASE | 0.12 MG/5ML |
| ORAL | SUSPENSION, LIQUID | 0.01 % |
| ORAL | SUSPENSION, SUSTAINED ACTION | 0.11 MG/5ML |
| ORAL | SYRUP | 0.95 % |
| ORAL | TABLET | 60.02 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 0.3 MG |
| ORAL | TABLET, CHEWABLE | 0.03 MG |
| ORAL | TABLET, COATED | 3.17 MG |
| ORAL | TABLET, DELAYED ACTION | 1.5 mg |
| ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 0.019 MG |
| ORAL | TABLET, EXTENDED RELEASE | 2.87 MG |
| ORAL | TABLET, FILM COATED | 1 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING | 1.36 MG |
| ORAL | TABLET, REPEAT ACTION | 0.02 MG |
| ORAL | TABLET, SUSTAINED ACTION | 1.06 MG |
| RECTAL | SOLUTION | 0.5 % |
| SUBLINGUAL | FILM | 0.02 MG |
| SUBLINGUAL | TABLET | 0.4 MG |
| TOPICAL | EMULSION, CREAM | NA |
| TOPICAL | GEL | 0.001 %W/W |
| TOPICAL | LOTION | 0.002 %W/W |
| TOPICAL | SPONGE | NA |